Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
Bristol Myers (BMY) delivered earnings and revenue surprises of +28.30% and +11.15%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Allegro MicroSystems (ALGM) delivered earnings and revenue surprises of +9.52% and +2.47%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
FIVE, CRDO and HPE made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 30, 2026.
Microsoft surged on Thursday following a blowout quarter.
Global payments technology company Mastercard (NYSE:MA) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 14.1% year on year to $9.28 billion. Its non-GAAP profit of $5.04 per share was 5.5% above analysts’ consensus estimates.
Event contracts brought in $156 million while crypto revenue fell 38% to $100 million
Revenue of $2.05 billion and EPS of $0.90 both beat consensus
A $266 million contract with the U.S. Space Force is another catalyst for the quickly growing space company.
Quanta Services, the nation's largest electrical infrastructure construction company, blew away second-quarter earnings forecasts and massively raised its full-year outlook amid the artificial intelligence buildout boom. Quanta said its improved visibility, record backlog and four recently completed acquisitions played into the big increase in its 2026 outlook. "We believe these results and our long-term track record are a clear differentiator of Quanta's ability to compound profitable growth as our customers accelerate investment in the electric grid, power generation and mission-critical infrastructure that underpin the economy," CEO Duke Austin said in the earnings statement.
Chip designer Allegro MicroSystems (NASDAQ:ALGM) announced better-than-expected revenue in Q2 CY2026, with sales up 27.5% year on year to $259.2 million. Guidance for next quarter’s revenue was optimistic at $270 million at the midpoint, 2.1% above analysts’ estimates. Its non-GAAP profit of $0.23 per share was 8.8% above analysts’ consensus estimates.
There's one investment Buffett has recommended for decades.
Strong sales of blood thinner Eliquis and newer drugs Camzyos and Reblozyl pushed second-quarter revenue to $12.97 billion, above analyst estimates
Goldman Sachs advised on transactions worth $437.7bn, while Houlihan Lokey ranked first by volume with 104 deals.
Crown Holdings, RTX and Kaiser Aluminum are highlighted as industrial stocks benefiting from resilient manufacturing, AI infrastructure demand and infrastructure spending.
Jim Cramer is struggling to find reasons to buy, and the Nasdaq 100 sliding into correction territory is not helping. Before you dismiss his caution, consider which corners of the market could actually benefit from the pain hitting semi stocks hardest.
Mastercard posted a rise in second-quarter profit on Thursday, boosted by robust transaction volumes driven by steady consumer spending. Its net income climbed to $4.4 billion, or $4.97 per share, in the quarter, compared with $3.7 billion, or $4.07 per share, a year earlier. (Reporting by Utkarsh Shetti in Bengaluru; Editing by Shinjini Ganguli)
Aerospace and defense company Huntington Ingalls (NYSE:HII) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 10.9% year on year to $3.42 billion. Its GAAP profit of $5.27 per share was 37.6% above analysts’ consensus estimates.
Canada Goose (GOOS) delivered earnings and revenue surprises of -1.59% and +6.96%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
These businesses are getting more alike by the day, but one has a better opportunity for generating long-term returns for shareholders.
Market leadership has shifted to value stocks amid a sell-off in tech stocks.
Barclays lowered its Robinhood price target to $105 from $122 and cited a meaningful slowdown in new accounts during July.
Wall Street is set to open higher on Thursday as strong Microsoft results helped technology stocks recover from their sharp post-Federal Reserve sell-off. Dow Jones futures were up 225 points, or 0.4%, while S&P 500 futures pointed to a 0.6% gain and the Nasdaq was called 1.3%...
The deal with the buzzy Flagship Pioneering-backed startup makes J&J the latest large drugmaker to bet that the technology might be able to treat autoimmune conditions.
Investing.com -- Bristol-Myers Squibb shares rose more than 1% in premarket trading Thursday after the drugmaker posted second-quarter results well ahead of expectations and raised its full-year guidance.
Valero Energy (VLO) delivered earnings and revenue surprises of +27.05% and +23.73%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Trane Technologies (TT) delivered earnings and revenue surprises of +0.94% and +2.86%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
As the Nasdaq wallows below its 50-day line, Schwab stock triggers the sweet sounds a breakout. Time to jump in?
<body><p>STORY: 2028... That's when Samsung says the chip shortage will extend until.</p><p>The world's biggest memory chipmaker posted a 250-fold jump in chip profit for the second quarter...</p><p>hitting $61.7 billion.</p><p>The South Korean firm signed multi-year supply deals with the five biggest global data center operators, and says it's nearing five more.</p><p>Samsung said almost all customers are now requesting multi-year contracts.</p><p>But the chip boom hurt another part of the business — Samsung's mobile division posted its first-ever loss of $484 million.</p><p>Samsung shares still fell 0.7% on the day, after climbing as much as 8.4% earlier.</p><p>Rival SK Hynix dropped 5.6%.</p><p>It follows a recent sell-off in chip stocks due to investor concerns about the mounting cost of AI infrastructure...</p><p>and competition from China that could squeeze earnings.</p><p>But Samsung's cash pile hit $116.3 billion, fueling expectations of big shareholder returns.</p></body>
The coffee chain posted its fourth straight quarter of comparable sales growth and now expects adjusted EPS of $2.55 to $2.65 for fiscal 2026
Can we count your visit with Google Analytics? No ads, no profiles. Details
